In February 2018, the Scottish Intercollegiate Guidelines Network (SIGN) published a new guideline on the pharmacological management of migraine (SIGN 155). This article discusses the main recommendations of the guidance… Click to show full abstract
In February 2018, the Scottish Intercollegiate Guidelines Network (SIGN) published a new guideline on the pharmacological management of migraine (SIGN 155). This article discusses the main recommendations of the guidance and how it compares with other UK headache guidelines, including NICE.
               
Click one of the above tabs to view related content.